Investors
Our drive for innovation, leadership, and value shapes our strategy and operations
Insights & Clarity
We prioritize trust , integrity , and respect in our investor relationships, offering the insights and clarity needed to understand our business
Strategically Positioned
Strategically poised for both immediate and long-term success.
01
Immediate revenue-generating platform of existing product offerings
Our technology enables our rapid commercialization of drug therapies through 503A compounding pharmacies. We also maintain a IP library spanning over 400 drug families.
02
Potential for FDA 505(b)(2) approval in or prior to 2027
Clear FDA 505(b)(2) pathway for drug approval, and on-going clinical trials with a national healthcare system for approval of alternative delivery systems, inhalable, chewable, coated capsules, etc.
03
Strong Pipeline for new drug development
Opportunity to commercialize or license additional products including Cannabidiol (CBD), and other applications of our coating technology.
We’re excited to share a summary of our operations.
Submit your request for an outline of Altanine’s strategies and financial outlook.
Thank You!
Your request has been received!
We will reach out to you shortly.
